Login Register Cart 0
Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

An Exploratory Review on the Hypoglycemic Action of Unani Anti-diabetic Drugs via Possible Modulation of Gut Microbiota

Author(s): Shaheen Akhlaq*, Shabnam Anjum Ara, Malik Itrat, Mohammad Fazil, Bilal Ahmad, Usama Akram, Merajul Haque, Neelam Quddusi and Ahmad Sayeed

Volume 25, Issue 1, 2024

Published on: 19 December, 2023

Page: [1 - 11] Pages: 11

DOI: 10.2174/0113894501275731231215101426

Price: $65

Abstract

Background and Aim: Diabetes mellitus is a chronic, multi-factorial metabolic disorder and also an important public health issue that requires multi-dimensional therapeutic strategies for effective control. Unani herbs have long been used to effectively mitigate diabetes through various mechanisms. In recent years, it has been speculated that the alteration of gut microbiome ecology is potentially one of the important mechanisms through which the Unani drugs exert hypoglycemic action. This review aims at the trans-disciplinary interpretation of the holistic concepts of the Unani system of medicine and the molecular insights of contemporary medicine for novel strategies for diabetes management.

Methodology: We searched scientific databases such as PubMed, Google Scholar, and Science-Direct, etc. Unani classical texts (Urdu, Arabic, and Persian), and medical books, for diabetic control with Unani medicine through the gut microbiome.

Results: Unani medicine defines, diabetes as a urinary system disorder disrupting the transformational faculty (Quwwat Mughayyira) in the gastrointestinal tract. The Unani system and contemporary biomedicine use different epistemology and ontology for describing diabetes through gutderived factors in whole-body glucose homeostasis. Unani Pharmaceutics have reported in clinical and preclinical (in vitro/ in vivo) trials in improving diabetes by altering gut microbiota composition, microvascular dysfunction, and inflammation. However, the preventive plan is the preservance of six essential factors (Asbāb Sitta Ḍarūriyya) as a lifestyle plan.

Conclusion: This is the first study on the integrative strategy about the hypoglycemic effects of Unani herbs that could serve as a prerogative novel approach for cost-effective, holistic, rationalistic, and multi-targeted diabetes management

Next »
Graphical Abstract

[1]
World Health Organisation (WHO). Diabetes. 2022. Available from: https://www.who.int/health-topics/diabetes#tab=tab_1 (Accessed on: 19 April 2022).
[2]
International Diabetes Federation (IDF). IDF Diabetes Atlas 2022. Available from: https://diabetesatlas.org/ (Accessed on: 10 Feb 2022).
[3]
Galtier F. Definition, epidemiology, risk factors. Diabetes Metab 2010; 36(6): 628-51.
[http://dx.doi.org/10.1016/j.diabet.2010.11.014] [PMID: 21163426]
[4]
Shakil A, Church RJ, Rao SS. Gastrointestinal complications of diabetes. Am Fam Physician 2008; 77(12): 1697-702.
[PMID: 18619079]
[5]
Albosta M, Bakke J. Intermittent fasting: Is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians. Clin Diabetes Endocrinol 2021; 7(1): 3.
[http://dx.doi.org/10.1186/s40842-020-00116-1] [PMID: 33531076]
[6]
Tokarek J, Gadzinowska J, Młynarska E, Franczyk B, Rysz J. What is the role of gut microbiota in obesity prevalence? a few words about gut microbiota and its association with obesity and related diseases. Microorganisms 2021; 10(1): 52.
[http://dx.doi.org/10.3390/microorganisms10010052] [PMID: 35056501]
[7]
Kumar S, Mittal A, Babu D, Mittal A. Herbal medicines for diabetes management and its secondary complications. Curr Diabetes Rev 2021; 17(4): 437-56.
[8]
Baghdadi HI. Kitabul Mukhtarat fil Tib. (3rd ed.). New Delhi, ND: CCRUM 2004; pp. 326-8.
[9]
Ibn Zuhar AMAM. Kitab al-Taisir Fil-Mudawat Wal-Tadbeer. New Delhi, ND: CCRUM 2000; pp. 160-63.
[10]
Rushd I. Kitab al-kulliyat. New Delhi, ND: CCRUM 1987; pp. 112-3.
[11]
Khan MA. Akseer-e-Azam. New Delhi, ND 2011; pp. 705-9.
[12]
Jurjani AH. Zakheera khwarzam shahi (Urdu). New Delhi, ND. Idara Kitab-us-Shifa 2010; 2010: 540-1.
[13]
Masihi AS. Kitab al mi’ata (Urdu), first ed. New Delhi, ND: CCRUM 2008; pp. 27-30. 122-133
[14]
Ara SA, Ahmad B, Fazil M, et al. Izkhar [Cymbopogon martinii (Roxb.)] Wats.: An evidence-based review on its phytochemical aspect and hepatoprotective traditional use in Unani medicine. J Herb Med 2022; 34: 100576.
[http://dx.doi.org/10.1016/j.hermed.2022.100576]
[15]
Hamdāni SKH. Usool -e tib (Urdu). New Delhi, ND: Qaumi Council baray firog Urdu zabaan 2011; pp. 39-43. 90, 111-124, 145-148
[16]
Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020; 21(17): 6275.
[http://dx.doi.org/10.3390/ijms21176275] [PMID: 32872570]
[17]
Sina I. Al Qanoon Fit Tib, Book I, English translation of the critical text. New Delhi, ND: Jamia Hamdard 1993; 131, 132: pp. 138-54.
[18]
Razi AMBZ. Kitab’al Hawi (Urdu) Vol 10th. New Delhi, ND: CCRUM 2002; pp. 181-91.
[19]
Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol 2019; 15(4): 226-37.
[http://dx.doi.org/10.1038/s41574-019-0168-8] [PMID: 30760847]
[20]
Temelkova-Kurktschiev T, Stefanov T. Lifestyle and genetics in obesity and type 2 diabetes. Exp Clin Endocrinol Diabetes 2012; 120(1): 1-6.
[http://dx.doi.org/10.1055/s-0031-1285832] [PMID: 21915815]
[21]
Perry BD, Caldow MK, Brennan-Speranza TC, et al. Muscle atrophy in patients with Type 2 Diabetes Mellitus: Roles of inflammatory pathways, physical activity and exercise. Exerc Immunol Rev 2016; 22: 94-109.
[PMID: 26859514]
[22]
Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18(1): 190-5.
[http://dx.doi.org/10.1038/oby.2009.167] [PMID: 19498350]
[23]
Harsch I, Konturek P. The role of gut microbiota in obesity and Type 2 and Type 1 Diabetes Mellitus: New insights into “Old” diseases. Med Sci 2018; 6(2): 32.
[http://dx.doi.org/10.3390/medsci6020032] [PMID: 29673211]
[24]
Li Q, Chang Y, Zhang K, Chen H, Tao S, Zhang Z. Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Sci Rep 2020; 10(1): 5450.
[http://dx.doi.org/10.1038/s41598-020-62224-3] [PMID: 32214153]
[25]
Holst JJ, Gasbjerg LS, Rosenkilde MM. The role of incretins on insulin function and glucose homeostasis. Endocrinology 2021; 162(7): bqab065.
[http://dx.doi.org/10.1210/endocr/bqab065] [PMID: 33782700]
[26]
Yang M, Fukui H, Eda H, et al. Involvement of gut microbiota in the association between gastrointestinal motility and 5-HT expression/M2 macrophage abundance in the gastrointestinal tract. Mol Med Rep 2017; 16(3): 3482-8.
[http://dx.doi.org/10.3892/mmr.2017.6955] [PMID: 28714029]
[27]
Labbé A, Ganopolsky JG, Martoni CJ, Prakash S, Jones ML. Bacterial bile metabolising gene abundance in Crohn’s, ulcerative colitis and type 2 diabetes metagenomes. PLoS One 2014; 9(12): e115175.
[http://dx.doi.org/10.1371/journal.pone.0115175] [PMID: 25517115]
[28]
Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56(7): 1761-72.
[http://dx.doi.org/10.2337/db06-1491] [PMID: 17456850]
[29]
Chu N, Chan JCN, Chow E. Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes. Front Endocrinol 2022; 13: 857090.
[http://dx.doi.org/10.3389/fendo.2022.857090] [PMID: 35600606]
[30]
Wolever TMS, Gibbs AL, Mehling C, et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: No effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 2008; 87(1): 114-25.
[http://dx.doi.org/10.1093/ajcn/87.1.114] [PMID: 18175744]
[31]
Akhlaq S, Ara SA, Ahmad B, et al. Interventions of Unani medicine for maintenance of health with special reference to air quality: an evidence-based review. Rev Environ Health 2023; 38(1): 85-96.
[http://dx.doi.org/10.1515/reveh-2021-0116] [PMID: 34883008]
[32]
Akhlaq S, Ara SA, Fazil M, et al. Ethno pharmacology, phytochemical analysis, safety profile, prophylactic aspects, and therapeutic potential of Asarum europaeum L. in Unani medicine: An evidence-based appraisal. Phytomedicine Plus 2022; 2(2): 100226.
[http://dx.doi.org/10.1016/j.phyplu.2022.100226]
[33]
León-Latre M, Moreno-Franco B, Andrés-Esteban EM, et al. Sedentary lifestyle and its relation to cardiovascular risk factors, insulin resistance and inflammatory profile. Rev Esp Cardiol 2014; 67(6): 449-55.
[http://dx.doi.org/10.1016/j.rec.2013.10.015] [PMID: 24863593]
[34]
Vanuytsel T, van Wanrooy S, Vanheel H, et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 2014; 63(8): 1293-9.
[http://dx.doi.org/10.1136/gutjnl-2013-305690] [PMID: 24153250]
[35]
Ghani MN. Khazainul Advia. New Delhi, ND: Idara Kitab al Shifa 2011; pp. 208-308. 321-442,468-70,489-1043,1061-1167,1215-1330
[36]
Rendón-Huerta JA, Juárez-Flores B, Pinos-Rodríguez JM, Aguirre-Rivera JR, Delgado-Portales RE. Effects of different sources of fructans on body weight, blood metabolites and fecal bacteria in normal and obese non-diabetic and diabetic rats. Plant Foods Hum Nutr 2012; 67(1): 64-70.
[http://dx.doi.org/10.1007/s11130-011-0266-9] [PMID: 22210166]
[37]
Feng R, Shou JW, Zhao ZX, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep 2015; 5(1): 12155.
[http://dx.doi.org/10.1038/srep12155] [PMID: 26174047]
[38]
Abliz A, Aji Q, Abdusalam E, et al. Effect of Cydonia oblonga Mill. leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia. J Ethnopharmacol 2014; 151(2): 970-4.
[http://dx.doi.org/10.1016/j.jep.2013.12.010] [PMID: 24342780]
[39]
Ansari P, Afroz N, Jalil S, et al. Anti-hyperglycemic activity of Aegle marmelos (L.) corr. is partly mediated by increased insulin secretion, α-amylase inhibition, and retardation of glucose absorption. J Pediatr Endocrinol Metab 2017; 30(1): 37-47.
[http://dx.doi.org/10.1515/jpem-2016-0160] [PMID: 28002030]
[40]
Zhong Y, Song B, Zheng C, et al. Flavonoids from mulberry leaves alleviate lipid dysmetabolism in high fat diet-fed mice: involvement of gut microbiota. Microorganisms 2020; 8(6): 860.
[http://dx.doi.org/10.3390/microorganisms8060860] [PMID: 32517288]
[41]
Xu J, Liu T, Li Y, et al. Jamun (Eugenia jambolana lam.) fruit extract prevents obesity by modulating the gut microbiome in high-fat-diet-fed mice. Mol Nutr Food Res 2019; 63(9): 1801307.
[http://dx.doi.org/10.1002/mnfr.201801307] [PMID: 30762938]
[42]
Liu W, Zhao S, Wang J, et al. Grape seed proanthocyanidin extract ameliorates inflammation and adiposity by modulating gut microbiota in high-fat diet mice. Mol Nutr Food Res 2017; 61(9): 1601082.
[http://dx.doi.org/10.1002/mnfr.201601082] [PMID: 28500724]
[43]
Zhao D, Cao J, Jin H, Shan Y, Fang J, Liu F. Beneficial impacts of fermented celery ( Apium graveolens L.) juice on obesity prevention and gut microbiota modulation in high-fat diet fed mice. Food Funct 2021; 12(19): 9151-64.
[http://dx.doi.org/10.1039/D1FO00560J] [PMID: 34606532]
[44]
Li S, You J, Wang Z, et al. Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice. Food Res Int 2021; 143: 110270.
[http://dx.doi.org/10.1016/j.foodres.2021.110270] [PMID: 33992371]
[45]
Gao H, Wen JJ, Hu JL, et al. Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats. Carbohydr Polym 2018; 201: 624-33.
[http://dx.doi.org/10.1016/j.carbpol.2018.08.075] [PMID: 30241862]
[46]
Dong J, Liang Q, Niu Y, et al. Effects of Nigella sativa seed polysaccharides on type 2 diabetic mice and gut microbiota. Int J Biol Macromol 2020; 159: 725-38.
[http://dx.doi.org/10.1016/j.ijbiomac.2020.05.042] [PMID: 32437806]
[47]
Harshavardhana HR, Krishna MS. High sugar induced changes in gut microflora in Drosophila melanogaster: Protective role of Gymnema sylvestre. Asian J Pharm Pharmacol 2019; 5(6): 1097-103.
[http://dx.doi.org/10.31024/ajpp.2019.5.6.4]
[48]
Kabiruddin M. Bayaz-e-Kabir (Urdu). (5th ed.). Hyderabad: Hikmat Book Depot 1935; pp. 177-9.
[49]
Ahmad N, Nawab M, Kazmi MH, Fatima SH. Evaluation of efficacy and safety of a polyherbal Unani formulation in diabetes mellitus type 2 (Zayābīṭus Sukkari Qism Sāni)-a randomised controlled clinical study. Indian J Tradit Knowl 2021; 20: 15-20.
[50]
Alam A, Siddiqui MY, Hakim MH. Clinical efficacy of Withania coagulans Dunal and Trigonella foenum-graecum L. in Type 2 Diabetes mellitus. Indian J Tradit Knowl 2009; V8: 405-9.
[51]
Eqbal K, Alam MA, Quamri MA, Sofi G, Ahmad Bhat MD. Efficacy of Qurs-e-Gulnar in Ziabetus (type 2 Diabetes Mellitus): A single blind randomized controlled trial. J Complement Integr Med 2021; 18(1): 147-53.
[http://dx.doi.org/10.1515/jcim-2020-0072] [PMID: 32554837]
[52]
Shamsi Y, Sharma M, Jabeen A, Akhtar W. Efficacy and Safety of a Polyherbal Unani drug as an Adjuvant Therapy in type-2 diabetes mellitus: A double blind, Randomized, Placebo Controlled Study. Fortune Health Sci 2022; 5(1): 43-57.
[http://dx.doi.org/10.26502/fjhs.045]
[53]
Alam A, Quamri S, Fatima S, Roqaiya M, Ahmad Z, Ahmad Z. Efficacy of spirulina (Tahlab) in patients of type 2 diabetes mellitus (Ziabetus shakri)-A randomized controlled trial. J Diabetes Metab 2016; 7(10): 1-5.
[http://dx.doi.org/10.4172/2155-6156.1000710]
[54]
Ansari AP, Nasir A. Therapeutic effect of ‘Qurs-i-Ziabetus Khas’ in diabetes mellitus-a case report. J Ayurvedic Herb Med 2020; 6: 4-8.
[http://dx.doi.org/10.31254/jahm.2020.6102]
[55]
Khan NA, Alam N, Eqbal K, Nahid G. Clinical efficacy of Unani formulation in type II diabetes-A randomized, single blind standard control clinical study. Int J Phys education, sports and health 2020.
[http://dx.doi.org/10.22271/kheljournal.2020.v7.i5c.1841]
[56]
Nasir A, Ansari AP, Rafeeqi TA, et al. Anti-diabetic potential of ‘Safūf-i-Dhayābītus’ as standalone and as an adjuvant with Glibenclamide in Streptozotocin-induced diabetic rats. Phytomedicine Plus 2020; 100218
[http://dx.doi.org/10.1016/j.phyplu.2022.100218]
[57]
Rahman IU, Idrees M, Rahman KU, Khan MI, Jan NU. Hypoglycemic potential of herbal product dolabi compared with pioglitazone in streptozotocin-induced diabetic rats. Chin J Integr Med 2016; 2016: 1-5.
[http://dx.doi.org/10.1007/s11655-016-2583-1] [PMID: 27220738]
[58]
Zainab K, Rehman SZ, Latif A, Jahan N. Hypoglycemic activity of Berg-e-Arusa and Shoneez. Indian J Tradit Knowl 2009; 8: 410-2.
[59]
Ahmed D, Sharma M, Mukerjee A, Ramteke PW, Kumar V. RETRACTED ARTICLE: Improved glycemic control, pancreas protective and hepatoprotective effect by traditional poly-herbal formulation “Qurs Tabasheer” in streptozotocin induced diabetic rats. BMC Complementary Medicine and Therapies 2013; 13(1): 10.
[http://dx.doi.org/10.1186/1472-6882-13-10] [PMID: 23305114]
[60]
Najmi AK, Sachdeva M, Shah S, Bhandari U, Pillai KK. Effect of Qurs-e-ziabetus-16 in neonatally streptozotocin induced diabetic rats. Indian J Pharmacol 1999; 31: 237.
[61]
Somani R, Shaikh A, Jain D, Shete R. Prokinetic effect of herbomineral unani formulation (dolabi) in diabetic rats. J Res Educ Indian Med 2012; XVIII: 1-6.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy